Stock Track | PomDoctor Surges 7.20% After-Hours Following Successful Nasdaq Debut

Stock Track10-09

PomDoctor (NASDAQ: POM), a leading online medical services platform for chronic diseases in China, saw its stock price soar 7.20% in after-hours trading on Wednesday, continuing its strong performance following its Nasdaq debut earlier in the day. The surge comes on the heels of the company's successful initial public offering (IPO) and impressive intraday trading results.

The company priced its IPO at $4.00 per American Depositary Share (ADS), offering 5,000,004 ADSs and raising approximately $20 million in gross proceeds. During regular trading hours, PomDoctor's stock had already shown significant strength, rising 5% from its IPO price to close at $4.20. The additional after-hours gain suggests continued investor enthusiasm for the newly public company.

PomDoctor's strong market debut and subsequent after-hours rally indicate positive investor sentiment towards the company's business model and growth prospects. As a platform focusing on chronic disease management and pharmaceutical services in China, PomDoctor aims to enhance the efficiency and transparency of the healthcare value chain. The successful IPO and robust trading performance may provide the company with increased visibility and resources to pursue its mission of becoming the most trustworthy medical and healthcare services platform in China.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1128958443?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-10-09 06:00","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1128958443","market":"hk","top_or_hot":-1,"title":"Stock Track | PomDoctor Surges 7.20% After-Hours Following Successful Nasdaq Debut","media":"Stock Track","content":"<p>PomDoctor (NASDAQ: POM), a leading online medical services platform for chronic diseases in China, saw its stock price soar 7.20% in after-hours trading on Wednesday, continuing its strong performance following its Nasdaq debut earlier in the day. The surge comes on the heels of the company's successful initial public offering (IPO) and impressive intraday trading results.</p>\n\n<p>The company priced its IPO at $4.00 per American Depositary Share (ADS), offering 5,000,004 ADSs and raising approximately $20 million in gross proceeds. During regular trading hours, PomDoctor's stock had already shown significant strength, rising 5% from its IPO price to close at $4.20. The additional after-hours gain suggests continued investor enthusiasm for the newly public company.</p>\n\n<p>PomDoctor's strong market debut and subsequent after-hours rally indicate positive investor sentiment towards the company's business model and growth prospects. As a platform focusing on chronic disease management and pharmaceutical services in China, PomDoctor aims to enhance the efficiency and transparency of the healthcare value chain. The successful IPO and robust trading performance may provide the company with increased visibility and resources to pursue its mission of becoming the most trustworthy medical and healthcare services platform in China.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | PomDoctor Surges 7.20% After-Hours Following Successful Nasdaq Debut</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | PomDoctor Surges 7.20% After-Hours Following Successful Nasdaq Debut\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2025-10-09 06:00</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>PomDoctor (NASDAQ: POM), a leading online medical services platform for chronic diseases in China, saw its stock price soar 7.20% in after-hours trading on Wednesday, continuing its strong performance following its Nasdaq debut earlier in the day. The surge comes on the heels of the company's successful initial public offering (IPO) and impressive intraday trading results.</p>\n\n<p>The company priced its IPO at $4.00 per American Depositary Share (ADS), offering 5,000,004 ADSs and raising approximately $20 million in gross proceeds. During regular trading hours, PomDoctor's stock had already shown significant strength, rising 5% from its IPO price to close at $4.20. The additional after-hours gain suggests continued investor enthusiasm for the newly public company.</p>\n\n<p>PomDoctor's strong market debut and subsequent after-hours rally indicate positive investor sentiment towards the company's business model and growth prospects. As a platform focusing on chronic disease management and pharmaceutical services in China, PomDoctor aims to enhance the efficiency and transparency of the healthcare value chain. The successful IPO and robust trading performance may provide the company with increased visibility and resources to pursue its mission of becoming the most trustworthy medical and healthcare services platform in China.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"POM","symbol_name":"石榴云医","start_time":0,"source_url":"","article_id":"1128958443","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1128958443","pubTimestamp":1759960851,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"PomDoctor (NASDAQ: POM), a leading online medical services platform for chronic diseases in China, saw its stock price soar 7.20% in after-hours trading on Wednesday, continuing its strong...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"POM":"石榴云医"},"translate_title":"个股轨迹|PomDoctor在纳斯达克成功上市后盘后大涨7.20%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"POM":1},"content_text":"PomDoctor (NASDAQ: POM), a leading online medical services platform for chronic diseases in China, saw its stock price soar 7.20% in after-hours trading on Wednesday, continuing its strong performance following its Nasdaq debut earlier in the day. The surge comes on the heels of the company's successful initial public offering (IPO) and impressive intraday trading results.\nThe company priced its IPO at $4.00 per American Depositary Share (ADS), offering 5,000,004 ADSs and raising approximately $20 million in gross proceeds. During regular trading hours, PomDoctor's stock had already shown significant strength, rising 5% from its IPO price to close at $4.20. The additional after-hours gain suggests continued investor enthusiasm for the newly public company.\nPomDoctor's strong market debut and subsequent after-hours rally indicate positive investor sentiment towards the company's business model and growth prospects. As a platform focusing on chronic disease management and pharmaceutical services in China, PomDoctor aims to enhance the efficiency and transparency of the healthcare value chain. The successful IPO and robust trading performance may provide the company with increased visibility and resources to pursue its mission of becoming the most trustworthy medical and healthcare services platform in China.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"2","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.13","shortVersion":"4.35.13","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1128958443","isCrawlerRequest":true}